Trials / Completed
CompletedNCT00829738
Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease
Pantoprazole 20/40 mg in Reflux-Associated Complaints With Focus on Gastrointestinal Symptoms
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,188 (actual)
- Sponsor
- Nycomed · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to evaluate the effect of 14 days treatment with Pantoprazole 40 mg and 20 mg on gastroesophageal reflux disease (GERD) related symptoms in a large patient population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pantoprazole | This was an observational study. Therefore, the physician decided about dosage according to individual needs (20 or 40 mg pantoprazole). |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-04-01
- Completion
- 2009-06-01
- First posted
- 2009-01-27
- Last updated
- 2012-05-08
- Results posted
- 2010-09-24
Locations
717 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00829738. Inclusion in this directory is not an endorsement.